UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 000-29440 IDENTIV, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of in ...

Financial Data and Key Metrics Changes - In Q3 2023, the company reported a GAAP net loss of $0.3 million or $0.01 per share, compared to a GAAP net income of $0.2 million in Q3 2022 and a loss of $1.5 million in Q2 2023 [14] - Non-GAAP adjusted EBITDA was $2.2 million, an increase of $0.1 million year-over-year and $1.5 million compared to Q2 2023, reflecting improved revenue and expanded gross margins [14] - The company exited Q3 2023 with $20.9 million in cash and cash equivalents, a decrease of $1.3 million from Q2 2023, while working capital increased to $49.8 million [15][22] Business Line Data and Key Metrics Changes - The Premises business grew 15% year-over-year to a record $13.6 million, with video software revenues more than doubling year-over-year [3][9] - The Identity segment's GAAP and non-GAAP adjusted gross margins were 21% and 23%, respectively, a decrease of 2% and 1% compared to Q3 2022, primarily due to a decline in gross margins in the Identity reader product line [86] - RFID-enabled IoT business shipped 54 million units in Q3, up 18% year-over-year, with a focus on high-margin SCRI applications in healthcare [96][120] Market Data and Key Metrics Changes - Federal revenues grew 16% year-over-year, despite challenges such as government budget confusion and a ransomware attack affecting a major federal integrator [7][9] - The company noted that the Premises business is growing at double the market rate, with strong contributions from both commercial and federal sectors [9][115] - The physical security sector is experiencing favorable trends, with investments in upgraded security infrastructure providing rapid ROI [8][112] Company Strategy and Development Direction - The company is moving to quarterly revenue guidance to provide clearer projections and manage expectations amid demand fluctuations [4][105] - A strategic review process is ongoing, focusing on optimizing value creation across both business units, with potential strategic actions expected in early 2024 [12][84] - The company aims to maintain a long-term non-GAAP adjusted gross margin target of 40% to 45% and is committed to expanding its presence in high-margin recurring revenue models [20][109] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in the healthcare sector, despite the slow-moving nature of approvals [120] - The company is closely monitoring demand fluctuations in lower-margin RFID applications while maintaining a strong balance sheet [25][106] - Management expects Q4 revenues to be in the range of $29 million to $31 million, reflecting a conservative outlook due to lower-margin RFID customer demand [32][105] Other Important Information - The company has over 50 customers in the $20,000 revenue range deploying new SCRI products at the pilot stage, with potential for significant annual revenue growth [5] - Inventory decreased by $1.7 million in Q3 as the company worked through strategic inventory balances [22] - The company is expanding its low-cost production capacity in Thailand to enhance cost competitiveness and support margin expansion [109] Q&A Session Summary Question: What is the outlook for the supply constraints? - Management indicated that supply constraints have been resolved, and they are cautiously optimistic about demand [30][141] Question: How do you expect operating expenses to trend in 2024? - Management expects operating expenses to remain at current levels throughout 2024 [36] Question: What is the status of FDA approvals for healthcare projects? - Management noted that most healthcare projects do not require FDA approval, but some specific projects do, which can slow down the process [149]

Q3 2023 Earnings Conference Call II DENTI Safe Harbor This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those involving future events and future results that are based on current expectations as well as the current beliefs and assumptions of the Company's management and can be identified by words such as "anticipates", "believes", "plans", "will", "intends", "expects", and similar references to the ...

II DENTI This presentation includes financial information that has not been prepared in accordance with GAAP, including non-GAAP adjusted EBITDA, non-GAAP adjusted EBITDA margin, non-GAAP gross margin, and non-GAAP operating expenses. Identiv uses non-GAAP financial measures internally in analyzing its financial results and believes they are useful to investors, as a supplement to GAAP measures, in evaluating our ongoing operational performance. We believe that the use of these non-GAAP financial measures p ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 000-29440 IDENTIV, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorpo ...

Identiv, Inc. (NASDAQ:INVE) Q2 2023 Earnings Conference Call August 3, 2023 5:00 PM ET Company Participants Steven Humphreys - Chief Executive Officer Justin Scarpulla - Chief Financial Officer Amir Khoshniyati - General Manager & Vice President-Transponder Business Manfred Mueller - Chief Operating Officer Conference Call Participants Craig Ellis - B. Riley Anthony Stoss - Craig-Hallum Jaeson Schmidt - Lake Street Operator Good afternoon. Welcome to Identiv's presentation of its Second Quarter Fiscal 2023 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 000-29440 IDENTIV, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorp ...

Identiv, Inc. (NASDAQ:INVE) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Steve Humphreys – Chief Executive Officer Justin Scarpulla – Chief Financial Officer Conference Call Participants Ethan Widell – B. Riley Securities Brian Ruttenbur – Imperial Capital Operator Good afternoon. Welcome to Identiv’s presentation of its First Quarter Fiscal 2023 Earnings Call. My name is Holly, and I’ll be your operator this afternoon. Joining us for today’s presentation are the company’s CE ...

Thursday, May 4, 2023, at 5:00PM EDT Safe Harbor Non-GAAP Financial Measures (Unaudited) This presentation contains trademarks, service marks, trade names and copyrights of Identiv and other companies, and are the property of their respective owners. Agenda 3 © 2023 Identiv, Inc. | All Rights Reserved | NASDAQ: INVE • Shipped 43 million units; maintained 100% RFID customer retention; supported 54 NRE projects • Chip availability improving; partnered with ProQure to launch new NFC Type 2 tags • Federal sales ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 0-29440 IDENTIV, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 77-0444317 (State or other jurisdiction of (I.R.S. Employer In ...